Covering the video games industry since 2017, with experience in news, articles, lists, and reviews (and I blame The Legend of Zelda: Majora's Mask for that). If you are a fan of RPGs and want a third ...
This article is part of Gizmodo Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Reading time 3 minutes The Eureka E20 Plus is a ...
Refresh for latest…: Lionsgate’s third outing with the Four Horsemen conjured a $75.5M global opening this weekend. Of that, $54.2M was in 64 international box office markets. The magic extended to No ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
McDonald’s is slashing the prices of its combo meals just a few weeks after the CEO publicly admitted that its menu has gotten too expensive and pledged to fix the problem. McDonald’s and its US ...
“Weapons,” a twisty horror film about a group of missing children, and “Freakier Friday,” a body swap comedy, delivered a potent one-two punch at the box office this weekend, lifting ticket sales as ...
There were two big-name new arrivals at the box office this past weekend, with Liam Neeson's reboot of The Naked Gun and the hotly anticipated animated sequel, The Bad Guys 2, debuting to good effect.
Rahul Malhotra is a Weekend News Writer for Collider. From Francois Ozon to David Fincher, he'll watch anything once. He has been writing for Collider for over two years, and has covered everything ...
Head and neck cancer, notoriously hard to treat, might have a new weakness—timing. Researchers discovered that syncing radiation and immunotherapy in just the right way can make tumors disappear in ...
AbbVie seeks FDA approval for Venclexta and Calquence combination for untreated CLL, following positive AMPLIFY trial results. The combination regimen showed a 35% reduction in disease progression or ...
A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for success to tee up a filing for FDA approval in the fourth quarter. The study ...
Prime Day is almost over, but there's still time to save on some of our favorite tech. One such deal is on the Roomba Robot Vacuum and Mop Combo, which is down to $140 for Prime members right now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results